Pfizer Launches Biosimilar Trastuzumab In US

Rival To Herceptin Competes In An Increasingly Crowded Market

 
• By David Wallace
  
F1
Pfizer has entered an increasingly crowded field with biosimilar trastuzumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products